2024-2028年体外膜氧合（ECMO）全球市场

预计2023-2028年体外膜氧合器市场将成长1.4504亿美元，预测期内复合年增长率为5.92%。

该报告包括对体外膜氧合器市场的总体分析、市场规模和预测、趋势、成长动力、挑战以及涵盖约 25 家供应商的供应商分析。

它提供了对当前市场状况、最新趋势和驱动因素以及整体市场环境的最新分析。该市场是由呼吸和心臟衰竭盛行率不断上升、新产品推出数量不断增加以及器官移植手术数量不断增加所推动的。

研究指出，ECMO设备的技术进步将是未来几年推动体外膜氧合市场成长的关键因素之一。此外，由于使用ECMO机器而导致呼吸衰竭患者的良好预后以及ECMO机器在儿童医学和治疗中的越来越多的采用也导致了巨大的市场需求。

目录

第一章执行摘要

• 市场概况

第二章 市场状况

• 市场生态系统

第三章 市场规模评估

• 市场定义
• 细分市场分析
• 2023 年市场规模
• 2023-2028年市场展望

第四章 市场规模表现

• 2018-2022年体外膜氧合器全球市场
• 2018-2022 年模式細項分析
• 2018-2022年产品細項分析
• 2018-2022 年区域細項分析
• 2018-2022 年国家細項分析

第五章五力分析

• 五力摘要
• 买方议价能力
• 供应商的议价能力
• 新进入者的威胁
• 替代品的威胁
• 竞争威胁
• 市场状况

第六章 按形态细分市场

• 细分市场
• 比较：按方式
• 静脉和动脉和静脉：2023-2028年市场规模和预测
• 静脉动脉：2023-2028 年市场规模与预测
• 市场机会：依方式分类

第七章 按产品细分市场

• 细分市场
• 比较：按产品
• ECMO设备：市场规模及2023-2028年预测
• 软体：2023-2028 年市场规模与预测
• 市场机会：依产品分类

第八章 客户状况

• 客户状况概览

第九章 地区情势

• 区域细分
• 区域比较
• 北美：2023-2028 年市场规模与预测
• 欧洲：2023-2028 年市场规模与预测
• 亚洲：2023-2028年市场规模与预测
• 世界其他地区：2023-2028 年市场规模与预测
• 美国：2023-2028 年市场规模与预测
• 德国：2023-2028年市场规模与预测
• 英国：2023-2028 年市场规模与预测
• 加拿大：2023-2028 年市场规模与预测
• 中国：2023-2028年市场规模及预测
• 市场机会：依地区状况

第 10 章 驱动因素、挑战与趋势

• 市场驱动因素
• 市场挑战
• 驱动因素和挑战的影响
• 市场趋势

第十一章 供应商情况

• 概述
• 供应商情况
• 混乱的情况
• 产业风险

第十二章供应商分析

• 交易厂商
• 供应商市场定位
• Abbott Laboratories
• Braile Biomedica
• Chalice Medical Ltd.
• Eurosets Srl
• Fresenius SE and Co. KGaA
• Getinge AB
• LivaNova PLC
• MC3 Cardiopulmonary
• Medtronic
• MicroPort Scientific Corp.
• Nipro Corp.
• OriGen Biomedical Inc.
• Sechrist Industries Inc.
• Senko Medical Instrument Mfg. Co. Ltd.
• Terumo Corp.

第十三章附录

The extracorporeal membrane oxygenation machines market is forecasted to grow by USD 145.04 mn during 2023-2028, accelerating at a CAGR of 5.92% during the forecast period. The report on the extracorporeal membrane oxygenation machines market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing incidence of respiratory and heart failure, rising number of new product launches, and growing number of organ transplant procedures.

Technavio's extracorporeal membrane oxygenation machines market is segmented as below:

By Modality

• Veno-venous and arterio-venous
• Veno-arterial

By Product

• ECMO machines
• Softwares

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the technological advancements in ECMO machines as one of the prime reasons driving the extracorporeal membrane oxygenation machines market growth during the next few years. Also, favorable outcomes in patients with respiratory failure due to use of ECMO machines and increasing adoption of ECMO machines in pediatric care and treatment will lead to sizable demand in the market.

The report on the extracorporeal membrane oxygenation machines market covers the following areas:

• Extracorporeal membrane oxygenation machines market sizing
• Extracorporeal membrane oxygenation machines market forecast
• Extracorporeal membrane oxygenation machines market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading extracorporeal membrane oxygenation machines market vendors that include Abbott Laboratories, Braile Biomedica, Chalice Medical Ltd., CytoSorbents Corp., Edwards Lifesciences Corp., Eurosets Srl, Fresenius SE and Co. KGaA, Gen World Medical Devices, Getinge AB, Johnson and Johnson Services Inc., LivaNova PLC, MC3 Cardiopulmonary, Medtronic, MicroPort Scientific Corp., Nipro Corp., OriGen Biomedical Inc., Sechrist Industries Inc., Senko Medical Instrument Mfg. Co. Ltd., Spectrum Medical Ltd., and Terumo Corp.. Also, the extracorporeal membrane oxygenation machines market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview

2 Market Landscape

• 2.1 Market ecosystem

3 Market Sizing

• 3.1 Market definition
• 3.2 Market segment analysis
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028

4 Historic Market Size

• 4.1 Global extracorporeal membrane oxygenation machines market 2018 - 2022
• 4.2 Modality Segment Analysis 2018 - 2022
• 4.3 Modality Segment Analysis 2018 - 2022
• 4.4 Product Segment Analysis 2018 - 2022
• 4.5 Geography Segment Analysis 2018 - 2022
• 4.6 Country Segment Analysis 2018 - 2022

5 Five Forces Analysis

• 5.1 Five forces summary
• 5.2 Bargaining power of buyers
• 5.3 Bargaining power of suppliers
• 5.4 Threat of new entrants
• 5.5 Threat of substitutes
• 5.6 Threat of rivalry
• 5.7 Market condition

6 Market Segmentation by Modality

• 6.1 Market segments
• 6.2 Comparison by Modality
• 6.3 Veno-venous and arterio-venous - Market size and forecast 2023-2028
• 6.4 Veno-arterial - Market size and forecast 2023-2028
• 6.5 Market opportunity by Modality

7 Market Segmentation by Product

• 7.1 Market segments
• 7.2 Comparison by Product
• 7.3 ECMO machines - Market size and forecast 2023-2028
• 7.4 Softwares - Market size and forecast 2023-2028
• 7.5 Market opportunity by Product

8 Customer Landscape

• 8.1 Customer landscape overview

9 Geographic Landscape

• 9.1 Geographic segmentation
• 9.2 Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• 9.4 Europe - Market size and forecast 2023-2028
• 9.5 Asia - Market size and forecast 2023-2028
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• 9.7 US - Market size and forecast 2023-2028
• 9.8 Germany - Market size and forecast 2023-2028
• 9.9 UK - Market size and forecast 2023-2028
• 9.10 Canada - Market size and forecast 2023-2028
• 9.11 China - Market size and forecast 2023-2028
• 9.12 Market opportunity By Geographical Landscape

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• 11.3 Landscape disruption
• 11.4 Industry risks

12 Vendor Analysis

• 12.1 Vendors covered
• 12.2 Market positioning of vendors
• 12.3 Abbott Laboratories
• 12.4 Braile Biomedica
• 12.5 Chalice Medical Ltd.
• 12.6 Eurosets Srl
• 12.7 Fresenius SE and Co. KGaA
• 12.8 Getinge AB
• 12.9 LivaNova PLC
• 12.10 MC3 Cardiopulmonary
• 12.11 Medtronic
• 12.12 MicroPort Scientific Corp.
• 12.13 Nipro Corp.
• 12.14 OriGen Biomedical Inc.
• 12.15 Sechrist Industries Inc.
• 12.16 Senko Medical Instrument Mfg. Co. Ltd.
• 12.17 Terumo Corp.

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• 13.3 Currency conversion rates for US$
• 13.4 Research methodology
• 13.5 List of abbreviations

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Modality
• Exhibits6: Executive Summary - Chart on Market Segmentation by Product
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits18: Historic Market Size - Data Table on global extracorporeal membrane oxygenation machines market 2018 - 2022 ($ million)
• Exhibits19: Historic Market Size - Modality Segment 2018 - 2022 ($ million)
• Exhibits20: Historic Market Size - Modality Segment 2018 - 2022 ($ million)
• Exhibits21: Historic Market Size - Product Segment 2018 - 2022 ($ million)
• Exhibits22: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• Exhibits23: Historic Market Size - Country Segment 2018 - 2022 ($ million)
• Exhibits24: Five forces analysis - Comparison between 2023 and 2028
• Exhibits25: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• Exhibits26: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• Exhibits27: Threat of new entrants - Impact of key factors in 2023 and 2028
• Exhibits28: Threat of substitutes - Impact of key factors in 2023 and 2028
• Exhibits29: Threat of rivalry - Impact of key factors in 2023 and 2028
• Exhibits30: Chart on Market condition - Five forces 2023 and 2028
• Exhibits31: Chart on Modality - Market share 2023-2028 (%)
• Exhibits32: Data Table on Modality - Market share 2023-2028 (%)
• Exhibits33: Chart on Comparison by Modality
• Exhibits34: Data Table on Comparison by Modality
• Exhibits35: Chart on Veno-venous and arterio-venous - Market size and forecast 2023-2028 ($ million)
• Exhibits36: Data Table on Veno-venous and arterio-venous - Market size and forecast 2023-2028 ($ million)
• Exhibits37: Chart on Veno-venous and arterio-venous - Year-over-year growth 2023-2028 (%)
• Exhibits38: Data Table on Veno-venous and arterio-venous - Year-over-year growth 2023-2028 (%)
• Exhibits39: Chart on Veno-arterial - Market size and forecast 2023-2028 ($ million)
• Exhibits40: Data Table on Veno-arterial - Market size and forecast 2023-2028 ($ million)
• Exhibits41: Chart on Veno-arterial - Year-over-year growth 2023-2028 (%)
• Exhibits42: Data Table on Veno-arterial - Year-over-year growth 2023-2028 (%)
• Exhibits43: Market opportunity by Modality ($ million)
• Exhibits44: Data Table on Market opportunity by Modality ($ million)
• Exhibits45: Chart on Product - Market share 2023-2028 (%)
• Exhibits46: Data Table on Product - Market share 2023-2028 (%)
• Exhibits47: Chart on Comparison by Product
• Exhibits48: Data Table on Comparison by Product
• Exhibits49: Chart on ECMO machines - Market size and forecast 2023-2028 ($ million)
• Exhibits50: Data Table on ECMO machines - Market size and forecast 2023-2028 ($ million)
• Exhibits51: Chart on ECMO machines - Year-over-year growth 2023-2028 (%)
• Exhibits52: Data Table on ECMO machines - Year-over-year growth 2023-2028 (%)
• Exhibits53: Chart on Softwares - Market size and forecast 2023-2028 ($ million)
• Exhibits54: Data Table on Softwares - Market size and forecast 2023-2028 ($ million)
• Exhibits55: Chart on Softwares - Year-over-year growth 2023-2028 (%)
• Exhibits56: Data Table on Softwares - Year-over-year growth 2023-2028 (%)
• Exhibits57: Market opportunity by Product ($ million)
• Exhibits58: Data Table on Market opportunity by Product ($ million)
• Exhibits59: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits60: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits61: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits62: Chart on Geographic comparison
• Exhibits63: Data Table on Geographic comparison
• Exhibits64: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits65: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits66: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibits67: Data Table on North America - Year-over-year growth 2023-2028 (%)
• Exhibits68: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits69: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits70: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits71: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits72: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits73: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits74: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits75: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits76: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits77: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits78: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits79: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits80: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibits81: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibits82: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibits83: Data Table on US - Year-over-year growth 2023-2028 (%)
• Exhibits84: Chart on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits85: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits86: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits87: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits88: Chart on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits89: Data Table on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits90: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibits91: Data Table on UK - Year-over-year growth 2023-2028 (%)
• Exhibits92: Chart on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibits93: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibits94: Chart on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits95: Data Table on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits96: Chart on China - Market size and forecast 2023-2028 ($ million)
• Exhibits97: Data Table on China - Market size and forecast 2023-2028 ($ million)
• Exhibits98: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibits99: Data Table on China - Year-over-year growth 2023-2028 (%)
• Exhibits100: Market opportunity By Geographical Landscape ($ million)
• Exhibits101: Data Tables on Market opportunity By Geographical Landscape ($ million)
• Exhibits102: Impact of drivers and challenges in 2023 and 2028
• Exhibits103: Overview on Criticality of inputs and Factors of differentiation
• Exhibits104: Overview on factors of disruption
• Exhibits105: Impact of key risks on business
• Exhibits106: Vendors covered
• Exhibits107: Matrix on vendor position and classification
• Exhibits108: Abbott Laboratories - Overview
• Exhibits109: Abbott Laboratories - Business segments
• Exhibits110: Abbott Laboratories - Key offerings
• Exhibits111: Abbott Laboratories - Segment focus
• Exhibits112: Braile Biomedica - Overview
• Exhibits113: Braile Biomedica - Product / Service
• Exhibits114: Braile Biomedica - Key offerings
• Exhibits115: Chalice Medical Ltd. - Overview
• Exhibits116: Chalice Medical Ltd. - Product / Service
• Exhibits117: Chalice Medical Ltd. - Key offerings
• Exhibits118: Eurosets Srl - Overview
• Exhibits119: Eurosets Srl - Product / Service
• Exhibits120: Eurosets Srl - Key offerings
• Exhibits121: Fresenius SE and Co. KGaA - Overview
• Exhibits122: Fresenius SE and Co. KGaA - Business segments
• Exhibits123: Fresenius SE and Co. KGaA - Key news
• Exhibits124: Fresenius SE and Co. KGaA - Key offerings
• Exhibits125: Fresenius SE and Co. KGaA - Segment focus
• Exhibits126: Getinge AB - Overview
• Exhibits127: Getinge AB - Business segments
• Exhibits128: Getinge AB - Key news
• Exhibits129: Getinge AB - Key offerings
• Exhibits130: Getinge AB - Segment focus
• Exhibits131: LivaNova PLC - Overview
• Exhibits132: LivaNova PLC - Business segments
• Exhibits133: LivaNova PLC - Key news
• Exhibits134: LivaNova PLC - Key offerings
• Exhibits135: LivaNova PLC - Segment focus
• Exhibits136: MC3 Cardiopulmonary - Overview
• Exhibits137: MC3 Cardiopulmonary - Product / Service
• Exhibits138: MC3 Cardiopulmonary - Key offerings
• Exhibits139: Medtronic - Overview
• Exhibits140: Medtronic - Business segments
• Exhibits141: Medtronic - Key news
• Exhibits142: Medtronic - Key offerings
• Exhibits143: Medtronic - Segment focus
• Exhibits144: MicroPort Scientific Corp. - Overview
• Exhibits145: MicroPort Scientific Corp. - Business segments
• Exhibits146: MicroPort Scientific Corp. - Key offerings
• Exhibits147: MicroPort Scientific Corp. - Segment focus
• Exhibits148: Nipro Corp. - Overview
• Exhibits149: Nipro Corp. - Business segments
• Exhibits150: Nipro Corp. - Key offerings
• Exhibits151: Nipro Corp. - Segment focus
• Exhibits152: OriGen Biomedical Inc. - Overview
• Exhibits153: OriGen Biomedical Inc. - Product / Service
• Exhibits154: OriGen Biomedical Inc. - Key offerings
• Exhibits155: Sechrist Industries Inc. - Overview
• Exhibits156: Sechrist Industries Inc. - Product / Service
• Exhibits157: Sechrist Industries Inc. - Key offerings
• Exhibits158: Senko Medical Instrument Mfg. Co. Ltd. - Overview
• Exhibits159: Senko Medical Instrument Mfg. Co. Ltd. - Product / Service
• Exhibits160: Senko Medical Instrument Mfg. Co. Ltd. - Key offerings
• Exhibits161: Terumo Corp. - Overview
• Exhibits162: Terumo Corp. - Business segments
• Exhibits163: Terumo Corp. - Key news
• Exhibits164: Terumo Corp. - Key offerings
• Exhibits165: Terumo Corp. - Segment focus
• Exhibits166: Inclusions checklist
• Exhibits167: Exclusions checklist
• Exhibits168: Currency conversion rates for US$
• Exhibits169: Research methodology
• Exhibits170: Validation techniques employed for market sizing
• Exhibits171: Information sources
• Exhibits172: List of abbreviations